Research ExplorerPublicationsInternational survey of acute stroke imaging used to make re...

International survey of acute stroke imaging used to make revascularization treatment decisions

Standard

International survey of acute stroke imaging used to make revascularization treatment decisions. / Wintermark, Max; Luby, Marie; Bornstein, Natan M; Demchuk, Andrew; Fiehler, Jens; Kudo, Kohsuke; Lees, Kennedy R; Liebeskind, David S; Michel, Patrik; Nogueira, Raul G; Parsons, Mark W; Sasaki, Makoto; Wardlaw, Joanna M; Wu, Ona; Zhang, Weiwei; Zhu, Guangming; Warach, Steven J.

In: INT J STROKE, Vol. 10, No. 5, 07.2015, p. 759-62.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Wintermark, M, Luby, M, Bornstein, NM, Demchuk, A, Fiehler, J, Kudo, K, Lees, KR, Liebeskind, DS, Michel, P, Nogueira, RG, Parsons, MW, Sasaki, M, Wardlaw, JM, Wu, O, Zhang, W, Zhu, G & Warach, SJ 2015, 'International survey of acute stroke imaging used to make revascularization treatment decisions', INT J STROKE, vol. 10, no. 5, pp. 759-62. https://doi.org/10.1111/ijs.12491

APA

Wintermark, M., Luby, M., Bornstein, N. M., Demchuk, A., Fiehler, J., Kudo, K., Lees, K. R., Liebeskind, D. S., Michel, P., Nogueira, R. G., Parsons, M. W., Sasaki, M., Wardlaw, J. M., Wu, O., Zhang, W., Zhu, G., & Warach, S. J. (2015). International survey of acute stroke imaging used to make revascularization treatment decisions. INT J STROKE, 10(5), 759-62. https://doi.org/10.1111/ijs.12491

Vancouver

Wintermark M, Luby M, Bornstein NM, Demchuk A, Fiehler J, Kudo K et al. International survey of acute stroke imaging used to make revascularization treatment decisions. INT J STROKE. 2015 Jul;10(5):759-62. https://doi.org/10.1111/ijs.12491

Bibtex

@article{fd595181f29d40ac99400ddd39efb741,
title = "International survey of acute stroke imaging used to make revascularization treatment decisions",
abstract = "BACKGROUND: To assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging.METHODS: STroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies.RESULTS: We received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25,326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (i.v.) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158) .CONCLUSION: There were significant variations among sites and geographical areas in terms of stroke imaging work-up used tomake decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.",
author = "Max Wintermark and Marie Luby and Bornstein, {Natan M} and Andrew Demchuk and Jens Fiehler and Kohsuke Kudo and Lees, {Kennedy R} and Liebeskind, {David S} and Patrik Michel and Nogueira, {Raul G} and Parsons, {Mark W} and Makoto Sasaki and Wardlaw, {Joanna M} and Ona Wu and Weiwei Zhang and Guangming Zhu and Warach, {Steven J}",
note = "{\textcopyright} 2015 World Stroke Organization.",
year = "2015",
month = jul,
doi = "10.1111/ijs.12491",
language = "English",
volume = "10",
pages = "759--62",
journal = "INT J STROKE",
issn = "1747-4930",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - International survey of acute stroke imaging used to make revascularization treatment decisions

AU - Wintermark, Max

AU - Luby, Marie

AU - Bornstein, Natan M

AU - Demchuk, Andrew

AU - Fiehler, Jens

AU - Kudo, Kohsuke

AU - Lees, Kennedy R

AU - Liebeskind, David S

AU - Michel, Patrik

AU - Nogueira, Raul G

AU - Parsons, Mark W

AU - Sasaki, Makoto

AU - Wardlaw, Joanna M

AU - Wu, Ona

AU - Zhang, Weiwei

AU - Zhu, Guangming

AU - Warach, Steven J

N1 - © 2015 World Stroke Organization.

PY - 2015/7

Y1 - 2015/7

N2 - BACKGROUND: To assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging.METHODS: STroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies.RESULTS: We received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25,326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (i.v.) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158) .CONCLUSION: There were significant variations among sites and geographical areas in terms of stroke imaging work-up used tomake decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.

AB - BACKGROUND: To assess the differences across continental regions in terms of stroke imaging obtained for making acute revascularization therapy decisions, and to identify obstacles to participating in randomized trials involving multimodal imaging.METHODS: STroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging circulated an online survey through its website, through the websites of national professional societies from multiple countries as well as through email distribution lists from STIR and the above mentioned societies.RESULTS: We received responses from 223 centers (2 from Africa, 38 from Asia, 10 from Australia, 101 from Europe, 4 from Middle East, 55 from North America, 13 from South America). In combination, the sites surveyed administered acute revascularization therapy to a total of 25,326 acute stroke patients in 2012. Seventy-three percent of these patients received intravenous (i.v.) tissue plasminogen activator (tPA), and 27%, endovascular therapy. Vascular imaging was routinely obtained in 79% (152/193) of sites for endovascular therapy decisions, and also as part of standard IV tPA treatment decisions at 46% (92/198) of sites. Modality, availability and use of acute vascular and perfusion imaging before revascularization varied substantially between geographical areas. The main obstacles to participate in randomized trials involving multimodal imaging included: mainly insufficient research support and staff (50%, 79/158) and infrequent use of multimodal imaging (27%, 43/158) .CONCLUSION: There were significant variations among sites and geographical areas in terms of stroke imaging work-up used tomake decisions both for intravenous and endovascular revascularization. Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.

U2 - 10.1111/ijs.12491

DO - 10.1111/ijs.12491

M3 - SCORING: Journal article

C2 - 25833105

VL - 10

SP - 759

EP - 762

JO - INT J STROKE

JF - INT J STROKE

SN - 1747-4930

IS - 5

ER -